动脉粥样硬化中差异表达铁死亡相关基因的鉴定：生物信息学分析
Identification of Differentially Expressed Ferroptosis-Related Genes in Atherosclerosis: Bioinformatics Analysis
DOI: 10.12677/acm.2024.1441187, PDF,   
作者: 邹志毅, 王 昆, 王士忠*：青岛大学附属医院心血管外科，山东 青岛；彭 垒：自贡市中医院外科，四川 自贡
关键词: 动脉粥样硬化；铁死亡；NOX4；生物信息学分析；氧化应激；Atherosclerosis； Ferroptosis； NOX4； Bioinformatics Analysis； Oxidative Stress
摘要: 目的：铁死亡在动脉粥样硬化的发生和发展中起着至关重要的作用。本研究旨在已有研究的基础上，通过生物信息学分析进一步筛选鉴定与动脉粥样硬化中铁死亡相关的差异表达基因。材料方法：首先，mRNA表达谱数据集GSE100927从基因表达综合数据库中筛选，并使用R软件(4.0.0版)分析与动脉粥样硬化和铁死亡相关的潜在差异表达基因。随后，对选定的候选基因进行蛋白质–蛋白质相互作用分析、基因本体富集分析和京都基因与基因组百科全书通路富集分析等研究，最终构建受试者工作曲线，来预测其功能。结果：我们通过差异性分析确定了23个可能的与动脉粥样硬化铁死亡相关的潜在靶点。进一步通过基因本体富集分析发现这些候选基因的功能可能主要与氧化应激有关。蛋白质–蛋白质相互作用网络展示出绝大多数候选靶点存在密切的相互作用。最终我们再次从23个候选的潜在靶点中筛选了2个基因作为关键基因，即HMOX1和NOX4。结论：生物信息学分析鉴定了23个潜在的动脉粥样硬化铁死亡相关差异表达基因，而HMOX1和NOX4这2个基因可能作为关键基因在动脉粥样硬化过程中发挥更关键的作用。本研究结果可能有助于进一步了解动脉粥样硬化的发病机制，并为进一步指导临床治疗提供重要依据。
Abstract: Purpose: Ferroptosis plays a crucial role in the development and progression of atherosclerosis. The aim of this study was to identify differentially expressed genes associated with ferroptosis in atherosclerosis through bioinformatics analysis. Materials and Methods: First, the mRNA expression profile dataset GSE100927 was screened from the comprehensive gene expression database and analyzed using R software (version 4.0.0) for potential differentially expressed genes associated with atherosclerosis and iron death. Subsequently, protein-protein interaction analysis, gene ontology enrichment analysis and Kyoto Gene and Genome Encyclopedia pathway enrichment analysis were performed on the selected candidate genes, and finally the subject working curve was constructed to predict their functions. Results: We identified 23 possible potential targets associated with ferroptosis through differential analysis. The function of these candidate genes may be mainly related to oxidative stress through gene ontology enrichment analysis. Protein-protein interaction networks show close interactions at most candidate targets. Finally, we selected two key genes, namely HMOX1 and NOX4, from the 23 candidate potential targets. Conclusion: Bioinformatics analysis identified 23 potential differentially expressed genes associated with ferroptosis in atherosclerosis, two genes, HMOX1 and NOX4, may play a more critical role as key genes in the process of atherosclerosis. The results of this study may help to further understand the pathogenesis of atherosclerosis and provide an important basis for further clinical treatment.
文章引用：邹志毅, 彭垒, 王昆, 王士忠. 动脉粥样硬化中差异表达铁死亡相关基因的鉴定：生物信息学分析[J]. 临床医学进展, 2024, 14(4): 1514-1528. https://doi.org/10.12677/acm.2024.1441187

参考文献

[1] Tabares-Guevara, J.H., Villa-Pulgarin, J.A. and Hernandez, J.C. (2021) Atherosclerosis: Immunopathogenesis and Strategies for Immunotherapy. Immunotherapy, 13, 1231-1244. [Google Scholar] [CrossRef] [PubMed]
[2] Hansson, G.K. and Hermansson, A. (2011) The Immune System in Atherosclerosis. Nature Immunology, 12, 204-212. [Google Scholar] [CrossRef] [PubMed]
[3] Libby, P. (2021) The Changing Landscape of Atherosclerosis. Nature, 592, 524-533. [Google Scholar] [CrossRef] [PubMed]
[4] Poznyak, A.V., Bharadwaj, D., Prasad, G., Grechko, A.V., Sazonova, M.A. and Orekhov, A.N. (2021) Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD. International Journal of Molecular Sciences, 22, Article 6702. [Google Scholar] [CrossRef] [PubMed]
[5] Qiao, L., Ma, J., Zhang, Z., Sui, W., Zhai, C., Xu, D., Wang, Z., Lu, H., Zhang, M., Zhang, C., Chen, W. and Zhang, Y. (2021) Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis. Circulation Research, 129, 1141-1157. [Google Scholar] [CrossRef] 
[6] Jia, M., Li, Q., Guo, J., Shi, W., Zhu, L., Huang, Y., Li, Y., Wang, L., Ma, S., Zhuang, T., Wang, X., Pan, Q., Wei, X., Qin, Y., Li, X., Jin, J., Zhi, X., Tang, J., Jing, Q., Li, S., Jiang, L., Qu, L., Osto, E., Zhang, J., Wang, X., Yu, B. and Meng, D. (2022) Deletion of BACH1 Attenuates Atherosclerosis by Reducing Endothelial Inflammation. Circulation Research, 130, 1038-1055. [Google Scholar] [CrossRef] 
[7] Liu, W., Östberg, N., Yalcinkaya, M., Dou, H., Endo-Umeda, K., Tang, Y., Hou, X., Xiao, T., Fidler, T.P., Abramowicz, S., Yang, Y.G., Soehnlein, O., Tall, A.R. and Wang, N. (2022) Erythroid Lineage Jak2V617F Expression Promotes Atherosclerosis through Erythrophagocytosis and Macrophage Ferroptosis. The Journal of Clinical Investigation, 132, e155724.
[8] Lin, L., Zhang, M.X., Zhang, L., Zhang, D., Li, C. and Li, Y.L. (2021) Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis. Frontiers in Cell and Developmental Biology, 9, Article 809955. [Google Scholar] [CrossRef] [PubMed]
[9] Poznyak, A.V., Nikiforov, N.G., Wu, W.K., Kirichenko, T.V. and Orekhov, A.N. (2021) Autophagy and Mitophagy as Essential Components of Atherosclerosis. Cells, 10, Article 443. [Google Scholar] [CrossRef] [PubMed]
[10] Fredman, G. and MacNamara, K.C. (2021) Atherosclerosis Is a Major Human Killer and Non-Resolving Inflammation Is a Prime Suspect. Cardiovascular Research, 117, 2563-2574. [Google Scholar] [CrossRef] [PubMed]
[11] Kong, P., Cui, Z.Y., Huang, X.F., Zhang, D.D., Guo, R.J. and Han, M. (2022) Inflammation and Atherosclerosis: Signaling Pathways and Therapeutic Intervention. Signal Transduction and Targeted Therapy, 7, Article No. 131. [Google Scholar] [CrossRef] [PubMed]
[12] Fang, X., Ardehali, H., Min, J. and Wang, F. (2023) The Molecular and Metabolic Landscape of Iron and Ferroptosis in Cardiovascular Disease. Nature Reviews Cardiology, 20, 7-23. [Google Scholar] [CrossRef] [PubMed]
[13] Li, M., Xin, S., Gu, R., Zheng, L., Hu, J., Zhang, R. and Dong, H. (2022) Novel Diagnostic Biomarkers Related to Oxidative Stress and Macrophage Ferroptosis in Atherosclerosis. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 8917947. [Google Scholar] [CrossRef] [PubMed]
[14] Zhou, Y., Zhou, H., Hua, L., Hou, C., Jia, Q., Chen, J., Zhang, S., Wang, Y., He, S. and Jia, E. (2021) Verification of Ferroptosis and Pyroptosis and Identification of PTGS2 as the Hub Gene in Human Coronary Artery Atherosclerosis. Free Radical Biology & Medicine, 171, 55-68. [Google Scholar] [CrossRef] [PubMed]
[15] Jiang, X., Stockwell, B.R. and Conrad, M. (2021) Ferroptosis: Mechanisms, Biology and Role in Disease. Nature Reviews Molecular Cell Biology, 22, 266-282. [Google Scholar] [CrossRef] [PubMed]
[16] Zhang, Y., Xin, L., Xiang, M., Shang, C., Wang, Y., Wang, Y., Cui, X. and Lu, Y. (2022) The Molecular Mechanisms of Ferroptosis and Its Role in Cardiovascular Disease. Biomedicine & Pharmacotherapy, 145, Article 112423. [Google Scholar] [CrossRef] [PubMed]
[17] Ouyang, S., You, J., Zhi, C., Li, P., Lin, X., Tan, X., Ma, W., Li, L. and Xie, W. (2021) Ferroptosis: The Potential Value Target in Atherosclerosis. Cell Death & Disease, 12, Article No. 782. [Google Scholar] [CrossRef] [PubMed]
[18] Chen, Y., Yi, X., Huo, B., He, Y., Guo, X., Zhang, Z., Zhong, X., Feng, X., Fang, Z.M., Zhu, X.H., Wei, X. and Jiang, D.S. (2022) BRD4770 Functions as a Novel Ferroptosis Inhibitor to Protect Against Aortic Dissection. Pharmacological Research, 177, Article 106122. [Google Scholar] [CrossRef] [PubMed]
[19] Wei, L., Wang, N., Li, R., Zhao, H., Zheng, X., Deng, Z., Sun, Z. and Xing, Z. (2022) Integrated Bioinformatics-Based Identification of Ferroptosis-Related Genes in Carotid Atherosclerosis. Disease Markers, 2022, Article ID: 3379883. [Google Scholar] [CrossRef] [PubMed]
[20] Wu, D., Hu, Q., Wang, Y., Jin, M., Tao, Z. and Wan, J. (2022) Identification of HMOX1 as a Critical Ferroptosis-Related Gene in Atherosclerosis. Frontiers in Cardiovascular Medicine, 9, Article 833642. [Google Scholar] [CrossRef] [PubMed]
[21] Meng, Q., Xu, Y., Ling, X., Liu, H., Ding, S., Wu, H., Yan, D., Fang, X., Li, T. and Liu, Q. (2022) Role of Ferroptosis-Related Genes in Coronary Atherosclerosis and Identification of Key Genes: Integration of Bioinformatics Analysis and Experimental Validation. BMC Cardiovascular Disorders, 22, Article No. 339. [Google Scholar] [CrossRef] [PubMed]
[22] Marques, V.B., Leal, M.A.S., Mageski, J.G.A., Fidelis, H.G., Nogueira, B.V., Vasquez, E.C., Meyrelles, S.D.S., Simões, M.R. and Dos Santos, L. (2019) Chronic Iron Overload Intensifies Atherosclerosis in Apolipoprotein E Deficient Mice: Role of Oxidative Stress and Endothelial Dysfunction. Life Sciences, 233, Article 116702. [Google Scholar] [CrossRef] [PubMed]
[23] Sampilvanjil, A., Karasawa, T., Yamada, N., Komada, T., Higashi, T., Baatarjav, C., Watanabe, S., Kamata, R., Ohno, N. and Takahashi, M. (2020) Cigarette Smoke Extract Induces Ferroptosis in Vascular Smooth Muscle Cells. American Journal of Physiology: Heart and Circulatory Physiology, 318, H508-H518. [Google Scholar] [CrossRef] [PubMed]
[24] Tabas, I., Williams, K.J. and Borén, J. (2007) Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications. Circulation, 116, 1832-1844. [Google Scholar] [CrossRef] 
[25] Xu, S., Pelisek, J. and Jin, Z.G. (2018) Atherosclerosis Is an Epigenetic Disease. Trends in Endocrinology and Metabolism, 29, 739-742. [Google Scholar] [CrossRef] [PubMed]
[26] Rader, D.J. and Daugherty, A. (2008) Translating Molecular Discoveries into New Therapies for Atherosclerosis. Nature, 451, 904-913. [Google Scholar] [CrossRef] [PubMed]
[27] Bäck, M., Yurdagul, A., Tabas, I., Öörni, K. and Kovanen, P.T. (2019) Inflammation and Its Resolution in Atherosclerosis: Mediators and Therapeutic Opportunities. Nature Reviews Cardiology, 16, 389-406. [Google Scholar] [CrossRef] [PubMed]
[28] Wolf, D. and Ley, K. (2019) Immunity and Inflammation in Atherosclerosis. Circulation Research, 124, 315-327. [Google Scholar] [CrossRef] 
[29] Canfrán-Duque, A., Rotllan, N., Zhang, X., Andrés-Blasco, I., Thompson, B.M., Sun, J., Price, N.L., Fernández-Fuertes, M., Fowler, J.W., Gómez-Coronado, D., Sessa, W.C., Giannarelli, C., Schneider, R.J., Tellides, G., McDonald, J.G., Fernández-Hernando, C. and Suárez, Y. (2023) Macrophage-Derived 25-Hydroxycholesterol Promotes Vascular Inflammation, Atherogenesis, and Lesion Remodeling. Circulation, 147, 388-408. [Google Scholar] [CrossRef] 
[30] Galaris, D., Barbouti, A. and Pantopoulos, K. (2019) Iron Homeostasis and Oxidative Stress: An Intimate Relationship. Biochimica et Biophysica Acta-Molecular Cell Research, 1866, Article 118535. [Google Scholar] [CrossRef] [PubMed]
[31] Weiland, A., Wang, Y., Wu, W., Lan, X., Han, X., Li, Q. and Wang, J. (2019) Ferroptosis and Its Role in Diverse Brain Diseases. Molecular Neurobiology, 56, 4880-4893. [Google Scholar] [CrossRef] [PubMed]
[32] Liu, J., Kuang, F., Kroemer, G., Klionsky, D.J., Kang, R. and Tang, D. (2020) Autophagy-Dependent Ferroptosis: Machinery and Regulation. Cell Chemical Biology, 27, 420-435. [Google Scholar] [CrossRef] [PubMed]
[33] Panda, S.K., Peng, V., Sudan, R., Ulezko Antonova, A., Di Luccia, B., Ohara, T.E., Fachi, J.L., Grajales-Reyes, G.E., Jaeger, N., Trsan, T., Gilfillan, S., Cella, M. and Colonna, M. (2023) Repression of the Aryl-Hydrocarbon Receptor Prevents Oxidative Stress and Ferroptosis of Intestinal Intraepithelial Lymphocytes. Immunity, 56, 797-812. [Google Scholar] [CrossRef] [PubMed]
[34] Li, J., Jia, B., Cheng, Y., Song, Y., Li, Q. and Luo, C. (2022) Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 3999083. [Google Scholar] [CrossRef] [PubMed]
[35] Li, J., Cao, F., Yin, H.L., Huang, Z.J., Lin, Z.T., Mao, N., Sun, B. and Wang, G. (2020) Ferroptosis: Past, Present and Future. Cell Death & Disease, 11, Aticle No. 88. [Google Scholar] [CrossRef] [PubMed]
[36] Wang, X., Chen, X., Zhou, W., Men, H., Bao, T., Sun, Y., Wang, Q., Tan, Y., Keller, B.B., Tong, Q., Zheng, Y. and Cai, L. (2022) Ferroptosis Is Essential for Diabetic Cardiomyopathy and Is Prevented by Sulforaphane via AMPK/NRF2 Pathways. Acta Pharmaceutica Sinica B, 12, 708-722. [Google Scholar] [CrossRef] [PubMed]
[37] Batty, M., Bennett, M.R. and Yu, E. (2022) The Role of Oxidative Stress in Atherosclerosis. Cells, 11, Article 3843. [Google Scholar] [CrossRef] [PubMed]
[38] Marchio, P., Guerra-Ojeda, S., Vila, J.M., Aldasoro, M., Victor, V.M. and Mauricio, M.D. (2019) Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 8563845. [Google Scholar] [CrossRef] [PubMed]
[39] Park, M.W., Cha, H.W., Kim, J., Kim, J.H., Yang, H., Yoon, S., Boonpraman, N., Yi, S.S., Yoo, I.D. and Moon, J.S. (2021) NOX4 Promotes Ferroptosis of Astrocytes by Oxidative Stress-Induced Lipid Peroxidation via the Impairment of Mitochondrial Metabolism in Alzheimer’s Diseases. Redox Biology, 41, Article 101947. [Google Scholar] [CrossRef] [PubMed]
[40] Bedard, K. and Krause, K.H. (2007) The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology. Physiological Reviews, 87, 245-313. [Google Scholar] [CrossRef] [PubMed]
[41] Zeeshan, H.M., Lee, G.H., Kim, H.R. and Chae, H.J. (2016) Endoplasmic Reticulum Stress and Associated ROS. International Journal of Molecular Sciences, 17, Article 327. [Google Scholar] [CrossRef] [PubMed]
[42] Vermot, A., Petit-Härtlein, I., Smith, S.M.E. and Fieschi, F. (2021) NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology. Antioxidants, 10, Article 890. [Google Scholar] [CrossRef] [PubMed]
[43] Jiang, J., Huang, K., Xu, S., Garcia, J.G.N., Wang, C. and Cai, H. (2020) Targeting NOX4 Alleviates Sepsis-Induced Acute Lung Injury via Attenuation of Redox-Sensitive Activation of CaMKII/ERK1/2/MLCK and Endothelial Cell Barrier Dysfunction. Redox Biology, 36, Article 101638. [Google Scholar] [CrossRef] [PubMed]
[44] Yu, W., Li, S., Wu, H., Hu, P., Chen, L., Zeng, C. and Tong, X. (2021) Endothelial Nox4 Dysfunction Aggravates Atherosclerosis by Inducing Endoplasmic Reticulum Stress and Soluble Epoxide Hydrolase. Free Radical Biology & Medicine, 164, 44-57. [Google Scholar] [CrossRef] [PubMed]
[45] Wang, W., Wu, Q.H., Sui, Y., Wang, Y. and Qiu, X. (2017) Rutin Protects Endothelial Dysfunction by Disturbing Nox4 and ROS-Sensitive NLRP3 Inflammasome. Biomedicine & Pharmacotherapy, 86, 32-40. [Google Scholar] [CrossRef] [PubMed]
[46] Gimbrone, M.A. and García-Cardeña, G. (2016) Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circulation Research, 118, 620-636. [Google Scholar] [CrossRef] 
[47] Stary, H.C. (2000) Natural History and Histological Classification of Atherosclerotic Lesions: An Update. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 1177-1178. [Google Scholar] [CrossRef] 
[48] Virmani, R., Kolodgie, F.D., Burke, A.P., Farb, A. and Schwartz, S.M. (2000) Lessons from Sudden Coronary Death: A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 1262-1275. [Google Scholar] [CrossRef] 
[49] Simionescu, N., Vasile, E., Lupu, F., Popescu, G. and Simionescu, M. (1986) Prelesional Events in Atherogenesis. Accumulation of Extracellular Cholesterol-Rich Liposomes in the Arterial Intima and Cardiac Valves of the Hyperlipidemic Rabbit. The American Journal of Pathology, 123, 109-125.
[50] Ross, R. and Glomset, J.A. (1973) Atherosclerosis and the Arterial Smooth Muscle Cell: Proliferation of Smooth Muscle Is a Key Event in the Genesis of the Lesions of Atherosclerosis. Science, 180, 1332-1339. [Google Scholar] [CrossRef] [PubMed]
[51] Ross, R. and Glomset, J.A. (1976) The Pathogenesis of Atherosclerosis (First of Two Parts). The New England Journal of Medicine, 295, 369-377. [Google Scholar] [CrossRef] 
[52] Ross, R. (1993) The Pathogenesis of Atherosclerosis: A Perspective for the 1990s. Nature, 362, 801-809. [Google Scholar] [CrossRef] [PubMed]
[53] Bedard, K., Lardy, B. and Krause, K.H. (2007) NOX Family NADPH Oxidases: Not Just in Mammals. Biochimie, 89, 1107-1112. [Google Scholar] [CrossRef] [PubMed]
[54] Hu, P., Wu, X., Khandelwal, A.R., Yu, W., Xu, Z., Chen, L., Yang, J., Weisbrod, R.M., Lee, K.S.S., Seta, F., Hammock, B.D., Cohen, R.A., Zeng, C. and Tong, X. (2017) Endothelial Nox4-Based NADPH Oxidase Regulates Atherosclerosis via Soluble Epoxide Hydrolase. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1863, 1382-1391. [Google Scholar] [CrossRef] [PubMed]
[55] Di Marco, E., Gray, S.P., Kennedy, K., Szyndralewiez, C., Lyle, A.N., Lassègue, B., Griendling, K.K., Cooper, M.E., Schmidt, H. and Jandeleit-Dahm, K.A.M. (2016) NOX4-Derived Reactive Oxygen Species Limit Fibrosis and Inhibit Proliferation of Vascular Smooth Muscle Cells in Diabetic Atherosclerosis. Free Radical Biology & Medicine, 97, 556-567. [Google Scholar] [CrossRef] [PubMed]
[56] Salazar, G. (2018) NADPH Oxidases and Mitochondria in Vascular Senescence. International Journal of Molecular Sciences, 19, Article 1327. [Google Scholar] [CrossRef] [PubMed]
[57] Ayer, A., Zarjou, A., Agarwal, A. and Stocker, R. (2016) Heme Oxygenases in Cardiovascular Health and Disease. Physiological Reviews, 96, 1449-1508. [Google Scholar] [CrossRef] [PubMed]
[58] Wang, Z., Li, W., Wang, X., Zhu, Q., Liu, L., Qiu, S., Zou, L., Liu, K., Li, G., Miao, H., Yang, Y., Jiang, C., Liu, Y., Shao, R., Wang, X. and Liu, Y. (2023) Isoliquiritigenin Induces HMOX1 and GPX4-Mediated Ferroptosis in Gallbladder Cancer Cells. Chinese Medical Journal, 136, 2210-2220. [Google Scholar] [CrossRef] 
[59] Fang, X., Wang, H., Han, D., Xie, E., Yang, X., Wei, J., Gu, S., Gao, F., Zhu, N., Yin, X., Cheng, Q., Zhang, P., Dai, W., Chen, J., Yang, F., Yang, H.T., Linkermann, A., Gu, W., Min, J. and Wang, F. (2019) Ferroptosis as a Target for Protection against Cardiomyopathy. Proceedings of the National Academy of Sciences of the United States of America, 116, 2672-2680. [Google Scholar] [CrossRef] [PubMed]
[60] Meng, Z., Liang, H., Zhao, J., Gao, J., Liu, C., Ma, X., Liu, J., Liang, B., Jiao, X., Cao, J. and Wang, Y. (2021) HMOX1 Upregulation Promotes Ferroptosis in Diabetic Atherosclerosis. Life Sciences, 284, Article 119935. [Google Scholar] [CrossRef] [PubMed]
[61] Yang, C., Wang, T., Zhao, Y., Meng, X., Ding, W., Wang, Q., Liu, C. and Deng, H. (2022) Flavonoid 4,4’-Dimethoxychalcone Induced Ferroptosis in Cancer Cells by Synergistically Activating Keap1/Nrf2/HMOX1 Pathway and Inhibiting FECH. Free Radical Biology & Medicine, 188, 14-23. [Google Scholar] [CrossRef] [PubMed]
[62] Zheng, C., Zhang, B., Li, Y., Liu, K., Wei, W., Liang, S., Guo, H., Ma, K., Liu, Y., Wang, J. and Liu, L. (2023) Donafenib and GSK-J4 Synergistically Induce Ferroptosis in Liver Cancer by Upregulating HMOX1 Expression. Advanced Science, 10, e2206798. [Google Scholar] [CrossRef] [PubMed]

为你推荐